Abstract:Researchers and clinicians often rely on molecular assays like PCR to identify and monitor viral infections, instead of the resource-prohibitive gold standard of viral culture. However, it remains unclear when (if ever) PCR measurements of viral load are reliable indicators of replicating or infectious virus. The recent popularity of PCR protocols targeting subgenomic RNA for SARS-CoV-2 has caused further confusion, as the relationships between subgenomic RNA and standard total RNA assays are incompletely characterized and opinions differ on which RNA type better predicts culture outcomes. Here, we explore these issues by comparing total RNA, subgenomic RNA, and viral culture results from 24 studies of SARS-CoV-2 in non-human primates (including 2167 samples from 174 individuals) using custom-developed Bayesian statistical models. On out-of-sample data, our best models predict subgenomic RNA positivity from total RNA data with 91% accuracy, and they predict culture positivity with 85% accuracy. Further analyses of individual time series indicate that many apparent prediction errors may arise from issues with assay sensitivity or sample processing, suggesting true accuracy may be higher than these estimates. Total RNA and subgenomic RNA showed equivalent performance as predictors of culture positivity. Multiple cofactors (including exposure conditions, host traits, and assay protocols) influence culture predictions, yielding insights into biological and methodological sources of variation in assay outcomes–and indicating that no single threshold value applies across study designs. We also show that our model can accurately predict when an individual is no longer infectious, illustrating the potential for future models trained on human data to guide clinical decisions on case isolation. Our work shows that meta-analysis of in vivo data can overcome longstanding challenges arising from limited sample sizes and can yield robust insights beyond those attainable from individual studies. Our analytical pipeline offers a framework to develop similar predictive tools in other virus-host systems, including models trained on human data, which could support laboratory analyses, medical decisions, and public health guidelines. Although viral culture is the gold-standard method to detect replicating and infectious virus, decisions in virology research, clinical diagnostics, and public health often must rely on faster, cheaper PCR assays that detect viral genetic material. Substantial scientific effort has focused on assessing whether PCR assays (and what kind of PCR assays) can accurately predict culture outcomes, often finding conflicting results. In our study, we address this long-standing question by developing a customized statistical approach to analyze a large database of non-human primates experimentally infected with SARS-CoV-2. We demonstrate that two common PCR protocols can predict viral culture results with similarly high accuracy, as long as interpretations account for other factors such as exposure conditions, demographics, and assay protocols. For example, we show that inoculated tissues are more likely to be culture-positive (for a given PCR result) on the first day post infection than all later days post infection or non-inoculated tissue on any day–a finding that will clarify interpretation of results in experimental studies. Beyond these biological findings, we also showed that our framework can accurately identify when an individual is no longer infectious, showing the potential for future versions (trained on human data) to offer an individualized approach to ending isolation. Overall, our work presents a standardized framework to quantitatively predict viral culture outcomes based on faster and cheaper assays, which can be readily adapted to any other pathogen-host system with relevant data. Our work also demonstrates the power of (Bayesian) meta-analysis, which will be essential for the new era of data sharing in virology.

Optimisation of SARS-CoV-2 culture from clinical samples for clinical trial applications

Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applications

Clinical validation of optimised RT-LAMP for the diagnosis of SARS-CoV-2 infection

A Benchmark of methods for SARS-CoV-2 whole genome sequencing and development of a more sensitive method

Accurate evaluation of live-virus microneutralization for SARS-CoV-2 variant JN.1

Culturing of SARS-CoV-2 from patient samples: Protocol for optimal virus recovery and assessment of infectious viral load

Optimisation and evaluation of viral genomic sequencing of SARS-CoV-2 rapid diagnostic tests: a laboratory and cohort-based study

Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets

Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application.

Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management

Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets

Performance of rapid antigen tests to detect SARS-CoV-2 variant diversity and correlation with viral culture positivity: implication for diagnostic development and future public health strategies

Development of a novel medium throughput flow-cytometry based micro-neutralisation test for SARS-CoV-2 with applications in clinical vaccine trials and antibody screening

Evaluating and optimizing Acid-pH and Direct Lysis RNA extraction for SARS-CoV-2 RNA detection in whole saliva

Development and translation of a method of clinical utility for LC-MS/MS analysis to detect SARS-CoV-2 antigens from ONP swabs and saliva

Test accuracy of rapid diagnostic tests and reverse-transcription polymerase chain reaction against virus isolation in cell culture for assessing SARS-CoV-2 infectivity: Systematic review and meta-analysis

Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates

A novel strategy to avoid sensitivity loss in pooled testing for SARS-CoV-2 surveillance: validation using nasopharyngeal swab and saliva samples

Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review

Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern

Comparative evaluation of cost effective extraction free molecular technique for detection of SARS-CoV-2 with reference to standard VTM based RT-qPCR method